Clinical Trials Study
Copyright ©The Author(s) 2017.
World J Gastroenterol. Apr 28, 2017; 23(16): 2978-2986
Published online Apr 28, 2017. doi: 10.3748/wjg.v23.i16.2978
Table 1 Baseline clinical data of patients before treatment
DNA expression level at 24-wk (IU/mL)
P value
< 1010-103> 103
Number of cases547147
Gender (male/female)39/1659/1226/210.108
Age (yr)37.79 ± 8.6839.33 ± 6.9235.82 ± 10.080.181
ALT (U/L) median (range)333 (80-897)367 (84-813)319 (82-965)0.212
AST (U/L)206.73 ± 133.09183 ± 147.19177 ± 109.850.323
PLT (109/L)203.02 ± 70.16263.33 ± 96.15176.86 ± 62.030.109
Total bilirubin (μmol/L)12.19 ± 4.0711.26 ± 6.339.08 ± 100.750.791
Albumin (g/L)43.12 ± 8.2445.39 ± 7.1542.29 ± 7.290.838
HBV DNA (log10 IU/mL)7.37 ± 0.497.59 ± 0.637.26 ± 0.370.785
HBsAg (log10 IU/mL) median (range)3.78 (2.98-5.46)3.66 (3.03-5.71)3.49 (3.04-5.66)0.801
HBeAg (s/co) median (range)303.78 (1.32-5663.42)179.79 (1.92-6558.76)230.32 (1.65-6288.83)0.206